Skip to content
Screener

Ensysce Biosciences, Inc. ENSC Q3 2025 earnings

Reported November 14, 2025 · Before market open

Revenue$493.1KMiss by $206.9K
EPS-$1.29Miss by $0.44
Revenue estimate$700.0K
EPS estimate-$0.85

Next report

Nov 13, 2026 (in 2 months)
Revenue estimate$1.2M
EPS estimate-$0.19

FAQ

When did Ensysce Biosciences, Inc. report Q3 2025 earnings?
Ensysce Biosciences, Inc. (ENSC) reported Q3 2025 earnings on November 14, 2025 before market open.
What were Ensysce Biosciences, Inc.'s Q3 2025 revenue and EPS?
Ensysce Biosciences, Inc. reported revenue of $493.1K and eps of $-1.29 for Q3 2025.
Did Ensysce Biosciences, Inc. beat estimates in Q3 2025?
Revenue missed the consensus estimate of $700.0K by $206.9K. EPS missed the consensus estimate of $-0.85 by $0.44.
How did Ensysce Biosciences, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 85.6% from $3.4M a year earlier.
Where can I find Ensysce Biosciences, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001493152-25-023492) and the 10-Q periodic report (0001493152-25-023498) directly on SEC EDGAR. The filing index links above go to sec.gov.